Hot Investor Mandate: USA-Based Firm with Over $2B AUM Invests in Devices, Diagnostics, and Digital Health Companies in USA and Canada

22 Aug

A USA-based firm with over $2 billion USD under management invests in external venture capital funds, and also has a fund to make direct investments in early stage companies. The firm focuses on investing in startups with some connection to universities who have strong ties with the firm (such as IP developed at the university or R&D being performed there) but also makes some investments into outside startups.  Initial investments are typically made at an early stage, and most are from $250,000-1 million; the firm also makes follow-on investments. The firm invests primarily in the US and also considers opportunities in Canada.

The firm invests in a wide variety of technology sectors; in the life sciences, the fund is focused on diagnostics, medical devices, and innovative areas of digital health.  The firm is opportunistic and will consider life science innovations broadly; areas of high interest include cancer care, AI, machine learning, clinical decision support systems, and imaging.  The firm will consider investing at a very early stage of development.

In addition, the firm has an additional innovation capital program for developing innovative technology in the US Midwest, including resources for incubating and accelerating new life science startups.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: